By activating multiple downstream signaling pathways, such as PI3K/AKT, RAS/RAF/MEK/ERK, and JAK/STAT pathways, HER2 promotes cell proliferation, survival, and metabolic regulation, while also enhancing tumor cell migration and invasiveness. This evidence concerns the gene ERBB2 and neoplasm.